The store will not work correctly when cookies are disabled.
(3-boronopropyl)phosphonic acid
ID: ALA5275507
Chembl Id: CHEMBL5275507
Max Phase: Preclinical
Molecular Formula: C3H10BO5P
Molecular Weight: 167.89
Associated Items:
Names and Identifiers
Canonical SMILES: O=P(O)(O)CCCB(O)O
Standard InChI: InChI=1S/C3H10BO5P/c5-4(6)2-1-3-10(7,8)9/h5-6H,1-3H2,(H2,7,8,9)
Standard InChI Key: BEMHGRRBKBCTPH-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 167.89 | Molecular Weight (Monoisotopic): 168.0359 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
1. Kesharwani S, Sundriyal S.. (2021) Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective., 213 [PMID:33303239] [10.1016/j.ejmech.2020.113055] |